An MDS Evidence‐Based Review on Treatments for Huntington's Disease

Movement DisordersVolume 37, Issue 7 p. 1566-1567 Letters: Published Article An MDS Evidence-Based Review on Treatments for Huntington's Disease Nora E. Fritz PhD, PT, DPT, NCS, Corresponding Author Nora E. Fritz PhD, PT, DPT, NCS [email protected] orcid.org/0000-0002-4548-1077 Program in Physical Therapy and Department of Neurology, Wayne State University, Detroit, Michigan, USA Correspondence to: Dr. Nora E. Fritz, Program in Physical Therapy and Department of Neurology, Wayne State University, 259 Mack Avenue, 2324, Detroit, MI 48201, USA; E-mail: [email protected]Search for more papers by this authorMonica Busse PhD, Monica Busse PhD orcid.org/0000-0002-5331-5909 Centre for Trials Research, Cardiff University, Cardiff, UKSearch for more papers by this authorLisa M. Muratori PT, EdD, Lisa M. Muratori PT, EdD Department of Physical Therapy, Stony Brook University, Stony Brook, New York, USASearch for more papers by this authorAshwini K. Rao OTR, EdD, Ashwini K. Rao OTR, EdD orcid.org/0000-0002-7837-9116 Department of Rehabilitation & Regenerative Medicine (Program in Physical Therapy), GH Sergievsky Center, Columbia University Irving Medical Center, New York, New York, USASearch for more papers by this authorAnne Kloos PT, PhD, NCS, Anne Kloos PT, PhD, NCS Division of Physical Therapy, School of Health and Rehabilitation Sciences, Ohio State University, Columbus, Ohio, USASearch for more papers by this authorDeborah Kegelmeyer PT, DPT, MS, GCS, Deborah Kegelmeyer PT, DPT, MS, GCS Division of Physical Therapy, School of Health and Rehabilitation Sciences, Ohio State University, Columbus, Ohio, USASearch for more papers by this authorLori Quinn PT, EdD, Lori Quinn PT, EdD orcid.org/0000-0002-2982-923X Department of Biobehavioral Sciences, Teachers College, Columbia University, New York, New York, USASearch for more papers by this author Nora E. Fritz PhD, PT, DPT, NCS, Corresponding Author Nora E. Fritz PhD, PT, DPT, NCS [email protected] orcid.org/0000-0002-4548-1077 Program in Physical Therapy and Department of Neurology, Wayne State University, Detroit, Michigan, USA Correspondence to: Dr. Nora E. Fritz, Program in Physical Therapy and Department of Neurology, Wayne State University, 259 Mack Avenue, 2324, Detroit, MI 48201, USA; E-mail: [email protected]Search for more papers by this authorMonica Busse PhD, Monica Busse PhD orcid.org/0000-0002-5331-5909 Centre for Trials Research, Cardiff University, Cardiff, UKSearch for more papers by this authorLisa M. Muratori PT, EdD, Lisa M. Muratori PT, EdD Department of Physical Therapy, Stony Brook University, Stony Brook, New York, USASearch for more papers by this authorAshwini K. Rao OTR, EdD, Ashwini K. Rao OTR, EdD orcid.org/0000-0002-7837-9116 Department of Rehabilitation & Regenerative Medicine (Program in Physical Therapy), GH Sergievsky Center, Columbia University Irving Medical Center, New York, New York, USASearch for more papers by this authorAnne Kloos PT, PhD, NCS, Anne Kloos PT, PhD, NCS Division of Physical Therapy, School of Health and Rehabilitation Sciences, Ohio State University, Columbus, Ohio, USASearch for more papers by this authorDeborah Kegelmeyer PT, DPT, MS, GCS, Deborah Kegelmeyer PT, DPT, MS, GCS Division of Physical Therapy, School of Health and Rehabilitation Sciences, Ohio State University, Columbus, Ohio, USASearch for more papers by this authorLori Quinn PT, EdD, Lori Quinn PT, EdD orcid.org/0000-0002-2982-923X Department of Biobehavioral Sciences, Teachers College, Columbia University, New York, New York, USASearch for more papers by this author First published: 20 July 2022 https://doi.org/10.1002/mds.29059 Relevant conflicts of interest/financial disclosures: N.E.F. serves on the MS scientific advisory board for Helius Medical, is a consultant for TEVA, and has grant funding from the National Institutes of Health, the National Multiple Sclerosis Society, the Consortium of Multiple Sclerosis Centers, and TEVA Pharmaceuticals unrelated to the submitted work. M.B. is a member of the STEMM1 (Medicine and Medical Sciences) Learned Society Scrutiny committee, a member of the NIHR HTA Commissioning Funding panel, and a member of the NIHR Clinical Trials Unit Standing Advisory Committee; serves on the advisory board for Health and Care Economics Cymru; and is an invited member of the DHSC/UKRI COVID-19 Rapid Response Rolling Call—College of Experts, a member of the global Enroll-HD Scientific Planning Committee, and a member of the European Huntington's Disease Network Clinical Trials Taskforce. She has grant funding from the National Institute for Health Research, Alzheimer Society, Jacques and Gloria Gossweiler Foundation, and Health and Care Research Wales unrelated to the submitted work. L.M.M. has grant funding from the Parkinson's Alliance, Global Wales Mobility Fund, Teva Pharmaceuticals, and Huntington's Disease Society of America unrelated to the submitted work. A.K.R. has grant funding from the National Institutes of Health and the National Science Foundation unrelated to the submitted work. A.K. receives royalties from McGraw Hill Education and has grant funding from the National Institutes of Health, The Michael J. Fox Foundation, the Huntington's Disease Society of America, and Teva Pharmaceuticals unrelated to the submitted work. D.K. receives royalties from McGraw Hill Publishers. She has grant funding from the National Institutes of Health, The Michael J. Fox Foundation, the Huntington's Disease Society of America, and Teva Pharmaceuticals unrelated to the submitted work. L.Q. serves on the advisory board for Spark Therapeutics. She receives honoraria from the Huntington Study Group and royalties from Elsevier Publishers. She has grant funding from the Parkinson's Foundation, The Michael J. Fox Foundation, Jacques and Gloria Gossweiler Foundation, and Teva Pharmaceuticals unrelated to the submitted work. Funding agency: None. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume37, Issue7July 2022Pages 1566-1567 RelatedInformation